Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 19-Apr-2014
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 7 of 7)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
17-Apr-14Thomson Reuters Stock ReportN/AThomson Reuters Stock Report - HIKMA PHARMACEUTICALS PLC (HIK-LN)11$25  View Abstract
16-Apr-14Wright ReportsN/AWright Investors Service Comprehensive Report for Hikma Pharmaceuticals PLC42$75  View Abstract
12-Apr-14Reuters Investment ProfileN/AHikma Pharmaceuticals PLC: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138  View Abstract
11-Apr-14GlobalDataGlobalDataHikma Pharmaceuticals PLC (HIK) - Financial and Strategic SWOT Analysis Review41$125  View Abstract
10-Apr-14Streetwise ReportsKeith MarkeyDon't Miss the Boat on Big Biotech Catalysts: Keith Markey9$92  View Abstract
18-Mar-14GlobalDataGlobalDataHikma Pharmaceuticals PLC (HIK) - Financial and Strategic SWOT Analysis Review41$125  View Abstract
12-Mar-14Thomson Reuters StreetEventsResearch DepartmentHIK.L - Event Transcript of Hikma Pharmaceuticals PLC conference call, Mar. 12, 2014 / 5:30AM ET17$75  View Abstract

Independent Reports (Showing 1 to 7 of 7)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
17-Apr-14Thomson Reuters Stock ReportN/AThomson Reuters Stock Report - HIKMA PHARMACEUTICALS PLC (HIK-LN)11$25View Abstract
16-Apr-14Wright ReportsN/AWright Investors Service Comprehensive Report for Hikma Pharmaceuticals PLC42$75View Abstract
12-Apr-14Reuters Investment ProfileN/AHikma Pharmaceuticals PLC: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138View Abstract
11-Apr-14GlobalDataGlobalDataHikma Pharmaceuticals PLC (HIK) - Financial and Strategic SWOT Analysis Review41$125View Abstract
10-Apr-14Streetwise ReportsKeith MarkeyDon't Miss the Boat on Big Biotech Catalysts: Keith Markey9$92View Abstract
18-Mar-14GlobalDataGlobalDataHikma Pharmaceuticals PLC (HIK) - Financial and Strategic SWOT Analysis Review41$125View Abstract
12-Mar-14Thomson Reuters StreetEventsResearch DepartmentHIK.L - Event Transcript of Hikma Pharmaceuticals PLC conference call, Mar. 12, 2014 / 5:30AM ET17$75View Abstract

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.